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A monoclonal antibody that blocks the light-activated cyclic GMP
(cGMP) pathway in frog photoreceptor outer segments (ROS) has been ob-
tained . The antibody (4A) inhibits guanine nucleotide binding to G-protein,
the intermediate that links rhodopsin excitation to cGMP phosphodiesterase
(PDE), inhibiting light-induced PDE activity as a consequence . Antibody inhi-
bition of the light-activated cGMP pathway is complete at a stoichiometry of
approximately one antibody per G-protein in the mixture, which indicates high
specificity of the inhibition . Inhibition is more pronounced than that caused by
PDE inhibitors such as isobutylmethylxanthine (IBMX) or Ro 20-1724 . Anti-
body 4A has the further effect of inhibiting the phosphorylation of two low
molecular weight proteins, components I and 11, whose phosphorylation nor-
mally can be stimulated by raisingcGMP levels . The inhibition is not overridden
by adding cGMP, which suggests that the G-protein influences these phospho-
rylations by a pathway distinct from its action on cGMP concentration . Antibody
4A may prove useful as a probe of the relevance of the cGMP pathway to visual
transduction in living photoreceptors . Six other monoclonal antibodies to G-
protein, as well as six monoclonal antibodies to rhodopsin and one to PDE, do
not block light-activated guanine nucleotide binding, PDE activity, or ROS
protein phosphorylations .
INTRODUCTION
In recent years, biochemical and physiological evidence has suggested a role of
cyclic GMP (cGMP) in visual transduction . Guanine nucleotide binding protein
(G-protein) and phosphodiesterase (PDE) make up two-thirds of the total non-
rhodopsin protein in the frog rod outer segment (ROS) (Hamm, H . E ., and M .
D . Bownds, manuscript submitted for publication) . Light activates these proteins
very rapidly (<100 ms) (Liebman and Pugh, 1979 ; Kuhn et al ., 1981 ; Bennett,
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1982) with a high stoichiometry (100-500 G-protein molecules activated per
rhodopsin bleached)(Fungand Stryer, 1980) . The light-activatedcGMP decrease
measured in isolated ROS (Woodruff and Bownds, 1979) and in physiologically
active ROS with inner segments attached (Biernbaum,M. S., C . S . Schobert, and
M . D. Bownds, manuscript submitted for publication) has correspondingly fast
kinetics and a high stoichiometry (Cote et al ., 1984).
Cyclic GMP can influence the physiological light response . Bathing the retina
with the PDE inhibitor isobutylmethylxanthine (IBMX) causes a depolarization
of the plasma membrane that is suppressible by light (Lipton et al ., 1977 ;
Capovilla et al ., 1982) . Intracellular injection of cGMP increases the latency of
the light response (Miller and Nichol, 1979 ; Miller, 1982) . Although these
findings suggest that cGMP maybe involved in visual transduction (Miller, 1982),
there is no simple relationship between cGMP levels and the light-induced
electrical response (Meyertholen et al ., 1980 ; WoodruffandFain, 1982) . Calcium
is also thought to play a central role in transduction (Hagins, 1972), for it is
rapidly extruded from outer segments upon illumination (Gold and Korenbrot,
1980 ; Yoshikami et al ., 1980). Calcium and cGMP levels are interrelated in the
outer segment cytoplasm (Cohen et al ., 1978 ; Woodruff and Bownds, 1979 ;
Polans et al ., 1979, 1981 ; Kilbride, 1980 ; Cavaggioni and Sorbi, 1981 ; Woodruff
and Fain, 1982 ; Hermolin et al ., 1982), but the details of this interaction are not
known.
To establish what pathways regulate transduction in vertebrate photorecep-
tors, it would be useful to obtain mutational blocks at a large number of different
steps in the process . Use of such blocks has been crucial in establishing the
sequence and branching pattern of complex metabolic pathways in microorga-
nisms (Tatum, 1959 ; Yanofsky, 1964) . An alternative has been to use drugs to
block known reactions (for example, the use of IBMX to inhibit PDE), but the
nonspecific effects of this and other pharmacological agents (Wells and Kramer,
1981) have made interpretation of data difficult .
Recent studies suggest that antibodies may prove to be generally useful as
specific blocking agents . Conventional sera and, more recently, monoclonal
antibodies have been found that bind specifically and tightly to the active sites
of their target enzymes, thereby blocking their function (Frackelton and Rotman,
1980 ; Clark et al ., 1981 ; Kaltoft et al ., 1982 ; Kiehart et al ., 1982) . Some
antibodies also restore function to mutant nonfunctional enzymes (Frackelton
and Rotman, 1980) . Inactivating monoclonal antibodies have been used to study
enzyme mechanisms(Mountford et al ., 1982), to identify the function of proteins
(Jay et al ., 1981 ; Clarket al ., 1981), to investigate structure-function relationships
on a protein's surface (Tzartos et al ., 1981 ; Gabay and Schwartz, 1982), and to
probe the intracellular role of particular enzyme activities (Kiehart et al ., 1982).
This paper describes the actions of an antibody to the guanine nucleotide
binding protein (G-protein) that blocks light-activated guanine nucleotide bind-
ing, cGMP phosphodiesterase activity, and the phosphorylation ofcomponents I
and 11 . This antibody may prove useful in evaluating the importance of the
cGMPpathwayin transduction . Thecompanion paper (Witt et al ., 1984) providesHAMM AND BOWNDS
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background material on generating and characterizing a first series of antibodies
to the more prominent proteins. A subsequent paper will describe the effect of
these antibodies on the physiological light response.
MATERIALS AND METHODS
Reaction ofAntibodies with ROS Proteins
Details of frog (Rana catesbeiana) maintenance, retinal dissection, and ROS purification
in Percoll step gradients are described in another paper (Hamm, H . E., and M. D. Bownds,
manuscript submitted for publication). The characterization and purification of the
monoclonal antibodies used in these studies are described in Witt et al. (1984). To allow
antibody access to the cell interior, 20 Al of Percoll-purified intact ROS (^-100 AM
rhodopsin) are disrupted and permeabilized by passage through a 26-gauge needle in the
presence of a purified antibody (-50 AM monoclonal IgG). Routinely a 10-fold excess of
antibody over G-protein is used. This preparation is allowed to incubate for 15-30 min
at room temperature to allow for antibody binding. The reaction mixture contains 50
kallikrein inhibitor units of Trasylol (aprotinin; FBA Pharmaceuticals, New York), a
protease inhibitor. This serves to keep the dark level of PDE activity constant during the
incubation step. Control treatmentsinclude Ringer's solution, commercially available IgG,
and IgG purified from ascites fluid of mice carrying tumors induced by the NS-1 parent
cell line (Witt et al., 1984).
PDE Activity Assay
The proton evolution assay of PDE, first developed by Yee and Liebman (1978) and used
in this laboratory by Kawamura and Bownds (1981), is used to screen for antibody effects.
The assay takes advantage of the fact that for every cGMP cleaved by the PDE, a proton
is produced. ROS are permeabilized as described above and incubated with antibody for
30 min, and then PDE activity is measured. The standard assay conditions are 4 mM
cGMP substrate, 0 .5 mM ATP, 0.5 mM GTP, 2.78 mM EGTA (free calcium, 10-9 M) in
200 Al frog Ringer's solution (115 mM NaCl, 2 mM KCI, 2 mM MgC12, 0 .1 mM CaC12,
10 mM Hepes, pH 7.8) containing5-7 AM rhodopsin; variations in conditions are specified
in the figure legends. Proton evolution is monitored continuously, before and after flashes
of light of increasing intensity. The maximal rate of proton evolution after a flash is
defined as the flash response. Between pH 7.5 and 8.0, the pH change measured by a pH
microelectrode is a linear function of PDE activity when the rhodopsin concentration is
^-5-7 AM. The buffering of this pH change by any component of the assay mixture was
determined as in Kawamura and Bownds (1981). Addition of antibodies does not change
the buffering of the mixture. PDE activity is expressed as moles of cGMP hydrolyzed per
mole rhodopsin per minute. The rhodopsin concentration was determined by difference
spectroscopy (Bownds et al., 1971).
Guanine Nucleotide Binding
Binding is measured by a method modified from Fung and Stryer (1980), which involves
specific binding of labeled GTP to ROS membranes followed by washing away unbound
nucleotide on Millipore filters and measuring bound nucleotide. To 50 AI ofpermeabilized
ROS, prepared as described above, which have been incubated for 30 min with specific
or control antibody, is added 200 Al of a reaction mixture containing 10 AM (85H]GTP,
10 kM GDP, 1 mM cGMP, with various amounts of calcium (see figure legends). Aliquots
are filtered through Millipore filters (type HA, 0 .45 AM) in the dark before and at various268
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times after a flash of light ; then filters are washed with Ringer's solution and bound
tritium is measured by liquid scintillation counting .
Protein Phosphorylation
A mixture of 20 Al purified ROS disrupted as described above in the presence of specific
or control antibody is incubated for 10 min with 30 A,1 of 10 AM [7s2P]ATP (10 AO), and
various concentrations of GTP, cGMP, and calcium, dependingon theexperiment . After
light treatment, samples are quenched with 200 Al 10% trichloroacetic acid, dissolved in
solubilization solution (Polans et al ., 1979), and subjected to electrophoresis and autora-
diography according to the methods of Polans et al . (1979) and H. E. Hamm and M . D.
Bownds (manuscript submitted for publication) .
RESULTS
An Antibody to the Photoreceptor G-Protein Inhibits the Light-activated cGMP
Pathway
Monoclonal antibodies to several outersegment proteins (six to rhodopsin, seven
to G-protein, and one to PDE) were examined for their effects on the cGMP
pathway. These antibodies are characterized in the preceding paper (Witt et al .,
1984). PDE activity was measured because it might be altered by antibody-
induced perturbation at any of several earlier steps (rhodopsin-G-protein inter-
action, GTP binding, G.-G,3, subunit dissociation, or GaPDE interaction ; see
Fung et al ., 1981) . ROS were disrupted in the presence of antibody to allow
access to cytoplasmic space, and PDE activity was then measured .
Fig. 1 summarizes the effects on PDE activity of seven different G-protein
antibodies, indicated by the different symbols used . (The antibodies bind to the
a subunit of the G-protein [Witt et al ., 1984], which contains the GTP binding
site [Fung et al ., 1981].) After a 30-min preincubation with antibody, PDE
activity was measured in the dark (left set of data points). Then the maximal
activity elicited by flash intensities causing threshold, intermediate, and near-
saturating responses was determined . The dark- and light-stimulated PDE activ-
ities are two- to threefold higher than those reported by Kawamura and Bownds
(1981) because lower rhodopsin concentrations were used (cf. Robinson et al .,
1980) and the preparations aged during Percoll purification and preincubation
with antibody (cf. Kawamura and Bownds, 1981) .
All of the antibodies decrease the amplitude of light-induced PDE activity to
some degree, and a complete inhibition is observed with the antibody designated
4A (bottom curve, filled circles) . The PDE inhibition caused by 4A is complete
at low and intermediate light levels, but at the highest light intensities, at which
nearly all of the G-protein should be activated, a small light activation of PDE
can be seen . This suggests that either a small pool of G-protein is inaccessible to
the antibody, or that antibody inhibition is not complete . Control immunoglob-
ulin not directed againstROS proteins (top curve, open triangles) has little effect
on PDE activity, compared with Ringer's solution (data not shown) . Fig . 1 shows
slight effects of the antibodies on dark levels of PDE activity . In most experi-
ments, no significant differences were found between dark levels of control and
specific antibodies (see, for example, Table I) .HAMM AND BoWNDS
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G-protein activity is assayed more directly in the experiment of Fig. 2, in which
guanine nucleotide binding to photoreceptor membranes is measured. This
figure shows that antibody 4A can suppress light-activated guanine nucleotide
binding. Permeabilized ROS were preincubated in the presence of control
immunoglobulin (open symbols) or antibody 4A (closed symbols). Dark levels
(left) of nucleotide binding are comparable in the two conditions, but antibody
4A suppresses >80% of light activation. This figure further shows that the
antibody block is maintained through calcium concentration changes known to
influence the PDE pathway (Kawamura and Bownds, 1981). The small differ-
ences in GTP binding caused by changing Ca" concentrations in the control
























RHODOPSIN MOLECULES BLEACHED/OUTER SEGMENT
FIGURE 1 .
￿
Several antibodies to G-protein influence light-activated PDE activity.
Percoll-purified ROS were disrupted in the presence ofantibody by passagethrough
a 26-gauge needle and then incubated at a concentration of 50 AM rhodopsin, 25
AM antibody for 30 min at room temperature. Portions (20 Al) were diluted to 200
A] (final concentration, 10-9 MCa", 0.5 mM GTP, 0.5 mM ATP, 5-7 AM rhodopsin
in frog Ringer's, pH 7.8) and immediately assayed for PDE activity in the dark and
after flashes of light of increasing intensities.
is more completely blocked by antibody 4A (data not shown). Thus, antibody
4A inhibits light-activated nucleotide binding to G-protein without changing
binding in the dark .
Several other antibodies were screened for effects on PDE activity, including
six antibodies to rhodopsin and one to PDE. Two of the rhodopsin antibodies
decreased both dark- and light-activated PDE by ^-30%, while the other had no
effect . The PDE antibody had no effect on PDE activity.
Characterization ofAntibody 4A Inhibition
Fig. 3A shows that the antibody inhibition, measured by its effect on PDE
activity, is evident by 5 min incubation with antibody 4A, and is essentially
complete by 10 min. Thus, the antibody binding is rapid, a characteristic270
necessary for experiments in which the antibody is introduced into living pho-
toreceptors to examine its effects on the physiological light response . Fig . 3B
demonstrates that the inhibition decreases with antibody dilution . The stoichi-
ometry at which maximal inhibition occurs is approximately one antibody per
G-protein molecule . (This is calculated by determining antibody concentration
by absorbance at 280nm [assuming A i °m = 13 .5 ; Kirschenbaum, 1973], rhodop-
sin concentration by difference spectroscopy [Bowndset al ., 1971 ], and G-protein


















TIME AFTER FLASH (min)
FIGURE 2 .
￿
G-protein antibody 4A inhibits light-activated guaninenucleotide bind-
ing . Here, the effect of a near-saturating light on guanine nucleotide binding was
measured after preincubation with commercially obtained nonspecific IgG (open
symbols) or purified antibody 4A (closed symbols). Percoll-purified intact ROS were
disrupted and incubated with antibody as in Fig. 1 . Then a reaction mixture
containing (final concentrations) 10 AM GTP (0.1 AM [8--'H]GTP), 10 AM GDP, 1
mM cGMP, and either 10-4 M (circles), 10'M (triangles), or 10-8 M (squares)
calcium was added and guanine nucleotide binding was measured in the dark and
after a flash of light bleaching 2 X 105 rhodopsin/outer segment by filtration
through Millipore filters .
[Hamm, H . E., andM . D . Bownds, manuscript submitted for publication] .) This
result, combined with the lack of effect of control antibody, suggests that the
inhibition is a specific antibody effect and is not caused by a contaminant in the
purified antibody preparation . It further shows that the antibody binds strongly
to G-protein .
The data shown in Table I contrast the inhibition of PDE caused by antibody







































MOLES ANTIBODY 4A/MOLE G-PROTEIN
FIGURE 3 .
￿
Time course and stoichiometry of antibody 4A inhibitory effect on
PDE activity . (A) The antibody inhibition is apparent as soon after antibody addition
as PDE activity can be measured, and is essentially complete after 10 min incubation .
Permeabilized ROS were preincubated with antibody 4A for various amounts of
time, and then PDE activity was measured under standard conditions . (B) Antibody
inhibition is essentially complete when the G-protein antibody ratio is 1 :1 .5 (at a
concentration of 3 uM G-protein, 4.5,uM antibody) . Here, permeabilized ROS were
preincubated for 30 min with the normal antibody concentration (15-fold molar
excess) or with antibody diluted in Ringer's solution . Circles : flash bleaching 2 x
105 rhodopsins/outer segment ; triangles : 2 x 104 rhodopsins bleached/outer seg-
ment ; squares : 104 rhodopsins bleached/outer segment .
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recent electrophysiological studies (Lipton et al ., 1977 ; Capovilla et al ., 1982) .
The antibody inhibits only the light-activated PDE without perturbing dark
activity . The drugs, even at high concentration, decrease dark and illuminated
PDE activity to a similar degree and the relative activation by light over dark
levels is unchanged (^-300%) . Thus, the effects of these drugs on the light-
stimulated PDE are neither as potent nor as specific as the antibody effect .
Antibody 4A Inhibits the Phosphorylation of Components I and II
Cyclic nucleotide pathways frequently regulate multiple protein phosphorylations
(cf. Cohen, 1982), and thus it is relevant .to examine the effect of antibody 4A,
as well as all of the other antibodies obtained, on the numerous protein phos-
TABLE I
Effects ofPDE Inhibitors on PDE Activity
PDE activity*
(moles cGMP hydrolyzed per mole rhodopsin per
minute)
* Assayed as described in Materials and Methods and the legend to Fig . 1 .
$ Numbers denote x ± SD (n) .
Numbers denote an average of two determinations that were within 10% of each
other .
' d,1-4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone .
phorylations observed in the outer segment, particularly those that have been
shown to be regulated by cGMP, light, or calcium (Hermolin et al ., 1982) . Fig .
4 shows one experiment in which disrupted ROS were incubated with Ringer's
solution, control antibody, or G-protein antibodies and with [y32P]ATP in both
the dark (left lane of each pair) and during illumination bleaching 1% of the
rhodopsin present (right lane of each pair). The dark bands seen in the autora-
diogram of the sodium dodecyl sulfate (SDS) gel indicate the typical protein
phosphorylation patterns observed . In these disrupted ROS preparations, light
causes phosphorylation of rhodopsin, but a dephosphorylation of two small
proteins (components I and 11) that occurs in vivo is lost (cf . Polaris et al ., 1979) .
Addition Dark Light




Ringer's solution 68.6±6.4 (5)t 200±30 (5) 292
4A 66±6 (3) 66±6 (3) 0
IBMX 4 mM 26§ 64 246
2 mM 26 56 215
0.5 mM 30 89 297
0.25 mM 40 116 290
Ro 20-17244 4 mM 38 95 232
2 mM 33 125 379
0.5 mM 40 149 373HAMMAND BOWNDS Monoclonal Antibody Inhibition of G-Protein 273
One might expect antibody 4A, because it inhibits only light-activated degra-
dation ofcGMP, to result in either no change or a slight increase in cGMP levels .
Because cGMP stimulates phosphorylation ofcomponents I and II (Polans et al .,
1979 ; Hermolin et al., 1982), corresponding effects in these phosphorylations
should be observed . The opposite result is obtained ; addition of 4A causes
FIGURE 4 .
￿
Antibody 4A has a specific inhibitory effect on component I phospho-
rylation and, to a lesser extent, component II phosphorylation . Six different G-
protein antibodies, as well as nonspecific antibody and control Ringer's solution,
were preincubated with disrupted outer segments as described in the Fig . 1 legend .
Their effects on protein phosphorylation patterns were measured by incubation
with ['Ys2P]ATP in frog Ringer's solution containing 10-9 M calcium, followed by
either 1 min continuous light bleaching 3 x 10' rhodopsins/outer segment (right
lane of each pair) or dark (left lane of each pair) .
inhibition of the phosphorylation of component I and, to a lesser extent, of
component II in both the light and the dark (Fig . 4, lanes 5 and 6) . In contrast,
altering cGMP levels causes equal effects on the two phosphorylations (Polans et
al ., 1979 ; Hermolin et al ., 1982). In addition to its inhibitory effect on the
phosphorylation of components I and II, antibody 4A occasionally stimulated274
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the phosphorylation of proteins of 12,500 and 50,000 daltons (5.72P, four out
of seven experiments, and 2.95P, one out of seven experiments, arrows, Fig . 4 ;
see Hamm, H . E., and M . D. Bownds, manuscript submitted for publication) .
Other G-protein antibodies had no effect on phosphorylationlevels of anyprotein
(lanes 7-16) .
The independence of the effects of cGMP and antibody 4A is further shown
in Fig. 5, which demonstrates that 4A inhibition of phosphorylation of compo-
nents I and 11 is not altered by cGMP addition . Thus, the antibody blocks the
cGMP stimulation of the phosphorylation that can normally be observed in
disrupted ROS. This same result is obtained in both high (10-s and 10-4 M) and
low (10-8and 10-9 M) calcium (data not shown) . Cyclic AMP also cannot override
the antibody effect (data not shown) .
Another interpretation of the antibody inhibition of the phosphorylation level
ofcomponents I and II is that the antibody blocks dephosphorylation, and thus
does not allow phosphate turnover and incorporation of radioactive phosphates .
However, the data of Fig . 5, which show the stimulation by cGMP of the
FIGURE 5 .
￿
Antibody 4A inhibits component I and, to a lesser extent, component
II phosphorylation independent of cGMP concentration . Here, the effects of anti-
body 4A or control Ringer's solution are measured in the dark either with or
without 1 mM cGMP . Rods were treated as in Fig. 4 .
phosphorylation ofcomponents I and 11 in the control lanes, suggest that more
phosphorylatable sites are present.
Antibodies to rhodopsin and PDE, as well as to G-protein, were screened for
effects on phosphorylation . None of the antibodies tested had any effect on
rhodopsin phosphorylation or on any other protein phosphorylation, either in
the light or dark .
DISCUSSION
Antibody 4A, directed against G-protein, presents several useful features as an
inhibitor of the light-sensitive cGMP pathway when compared with PDE inhibi-
tors now in common use. Because it does not alter the dark activity of PDE, its
introduction into a living cell might be expected not to perturbcGMP levels or
aspects of dark current regulation that depend on these levels . Addition of PDE
inhibitors to the system, on the other hand, causes a rise in dark cGMP levels
and an increase in plasma membrane permeability (cf. Capovilla et al ., 1982) . A
further characteristic of the antibody is that it causes almost complete inhibitionHAMM AND BOWNDS Monoclonal Antibody Inhibition ofG-Protein
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ofthe light-activated PDE activity, while the inhibition caused by even millimolar
levels of PDE inhibitors does not exceed 50-70%.
If the light-induced cGMP decrease is an obligatory step in the reaction
sequence connecting photon absorption to a plasma membrane conductance
change, then one would predict that introduction ofthe antibody inside a living
photoreceptor might lock it into a "dark state" in which normal cGMP levels are
not perturbed, but their light-induced decrease and the consequent conductance
change are blocked. IfcGMP is not involved in the initial conductance decrease,
but rather plays a role in the adaptation processes that follow, then its introduc-
tion into the cell might inhibit adaptation. Given the currently popular idea that
cGMP regulates some aspect ofcalcium transport (cf. George and Hagins, 1983),
it might prove interesting to examine the effect of the antibody on the activation
ofsodium/calcium exchange that occurs following illumination (Yau etal., 1981).
One practical issue has to be met before the G-protein antibody can be shown
to be useful in physiological studies. G-protein accounts for 17% of the total
protein of these structures with one copy being present for every 10 rhodopsin
molecules (Hamm, H. E., and M. D. Bownds, manuscript submitted for publica-
tion). It may prove difficult to introduce enough antibody into the cell using
conventional injection techniques to adequately block the cGMP pathway. Ex-
periments currently in progress, in which the antibody is being introduced into
tiger salamander photoreceptors by internal perfusion (Stern and Lisman, 1982),
offer the prospect ofovercoming the problem. It seems likely that this issue will
be less important with antibodies targeted toward minor components, such as
protein kinases, which are thought to be important in regulating transduction .
A detailed picture of the reaction sequence linking photoexcited rhodopsin to
PDE activation is now available (Fung and Stryer, 1980; Fung et al., 1981 ; Fung,
1983; Fung and Nash, 1983). G-protein has three subunits, all ofwhich must be
present for the binding of G-protein to excited rhodopsin that is required for
GTP attachment to the a subunit. As soon as GTP binds to the a subunit, it
dissociates from the 0 and 7 subunits, diffuses to PDE, and then activates it by
removing a small inhibitory subunit. The protein blotting experiments described
in the previous paper(Witt et al., 1984) demonstrate that antibody 4A and other
G-protein antibodies bind to the a subunit o£ G-protein. Thus, the block in
guanine nucleotide binding caused by antibody 4A introduces a lesion early in
the activation sequence. The antibody might act near the guanine nucleotide
binding site, ata more distant regulatory site, or at a site required for interaction
of excited rhodopsin with G-protein. It should be possible to resolve these
alternatives with the reconstitution systems now available (cf. Fung, 1983).
Another possible mechanism of inhibition is an antibody cross-linking of G-
protein molecules. To rule out an effect ofcross-linking on G-protein inhibition,
the experiments should be done with F(ab) fragments.
The finding that antibody 4A also causes inhibition of the phosphorylation of
two small proteins, components I and II, illustrates a further potential benefit of
studying antibody-induced lesions: new information on pathways may be ob-
tained. The results can be taken to suggest a more complex system than is276 THE JOURNAL OF GENERAL PHYSIOLOGY " VOLUME 84 " 1984
explained by a linear pathway linkingrhodopsin bleachingtoadephosphorylation
of components I and II (i .e ., rhodopsin + by --3- G-protein activation -~ PDE
activation -> cGMP decrease -* dephosphorylation ofcomponents I and 1I) . The
observation that 4A inhibits the protein phosphorylations independent of light
or cGMP levels suggests that a separate linkage between G-protein and the
phosphorylation of components I and II must be considered . One possibility is
that G-protein may have multiple functions; that is, it may also have the role, in
addition to activating PDE, of regulating the (unknown) function ofcomponents
I and 11 . (Guanine nucleotide binding proteins may have multiple roles in some
other systems; for example, insulin appears to stimulate cAMP PDE and protein
kinase via GTP and cholera toxin-dependent mechanisms [Heyworth et al .,
1983x, b; Marchmont and Houslay, 1980] . There are also examples of guanine
nucleotide binding proteins whose functions are independent of cyclic nucleo-
tides [Gomperts, 1983 ; Kaziro, 1978 ; Margolis and Wilson, 1978].) Another
possibility is that components I and II or their kinase is located very close to the
G-protein on the disk membrane, which is involved in early steps leading to PDE
activation, with the cGMP effect on their phosphorylation providing feedback
control.
Several other possible explanations ofthe4A inhibition, rather than suggesting
new interactions, are compatible with existing information. Ifcomponents I and
II are localized very close to the G-protein-PDE complex on the disk membrane,
binding of antibody to G-protein might sterically block access of protein kinase
to components I and 11 . This would require that components I and II or their
kinase be localized very close to the 4A antigenic site of G-protein, because
several of the other antibodies that bind with affinity to G-protein have no effect
on the phosphorylation of components I and 11 . Another possibility is that
antibody 4A interactsdirectly with the cGMP-dependent protein kinase to inhibit
it . Arguing against this, Witt et al . (1984) have observed that 4A binds only to
G-protein in Western blots (detection limit : 5 x 10`'% of total protein) and
immunoprecipitates only G-protein.
It is interesting that of the 14 monoclonal antibodies directed against rhodop-
sin, G-protein, or PDE, one has been shown to function as a specific enzyme
inhibitor, with potential usefulness in studies of the physiological role of the
cGMP pathway . The other antibodies apparently bind to antigenic sites not
involved in the functions we have measured . If this yield of inhibitory antibodies
persists as we generate further antibodies to other outer segment proteins
(rhodopsin kinase, other protein kinases, and plasma membrane components),
then the approach of generating the monoclonal antibodies as pathway blockers
may be justified . Antibodies that bind with high affinity but do not block activity
are proving useful for immunocytochemical localization, affinity purification, or
precipitation of active enzyme complexes.
G-protein, against which antibody 4A is directed, has been shown to have
major structural and functional homologies with the guanine nucleotide binding
proteins that mediate between hormone receptors and adenylate cyclase in
hormone-sensitive cells (Bitensky et al ., 1982 ; Abood et al ., 1982 ; Manning andHAMM AND BoWNDS
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Gilman, 1983). One might expect the antibody to produce inhibition in these
other systems, and current experiments (Hamm, H. E., M. D. Bownds, andJ. S.
Takahashi, manuscript submitted for publication) have shown such inhibition in
the a-adrenergic system of rat pineal membranes. Recent findings on these
homologies suggest that G-protein might have multiple functions. For example,
Manning and Gilman (1983) have found that the photoreceptor G-protein has
structural similarities with both inhibitory and stimulatory guanine nucleotide
binding proteins, and Abood et al. (1982) and VanDop et al. (1984) have found
that bovine photoreceptor G-protein can be ADP-ribosylated at different sites
by two toxins, cholera toxin and pertussis toxin, with different effects on its
function. Several other antibodies that have been generated to G-protein may
be useful in the future in establishing whether G-protein has roles other than
PDE regulation in the photoreceptor.
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